You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美国过敏及传染病研究所:阿斯利康提交新冠疫苗测试数据或不完整
阿思达克 03-23 15:27
《路透》报道,美国国家过敏及传染病研究所表示,数据安全监察组(The Data Safety Monitoring Board)质疑英国阿斯利康就其新冠疫苗提交的美国测试数据,可能包括过期资料,或未能就疫苗有效率提供完整资料。研究所促请阿斯利康与监察组合作,检视疫苗有效数据,确保数据最准确及最更新,且可尽快公开。

据阿斯利康提交的数据,公司与牛津大学研发的疫苗,在美国、智利及秘鲁测试中防止病徵的有效率为79%,且没有出现血凝固风险。有关数据显示在32,449名志愿者中,141人感染新冠。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account